Objective: A case-control study was performed to describe the characteristics of AFD and to evaluate the clinical differences between AFD and AD.
suppression of hypothalamic-pituitary-adrenal (HPA) function has been shown but sound evidence of permanent disturbance of adrenal gland function is lacking.
Objectives: The aim is to relate basal cortisol levels to: prior use of topical corticosteroids, disease activity and investigate the effect of topical steroid treatment during hospitalization.
Methods: Two groups of AD patients were evaluated: 25 inpatients with severe AD (group 1) and 28 outpatients with severe, but stabilized AD (group 2). During hospitalization patients were treated with potent topical corticosteroids (250-300 grams per week). In group 1 morning basal serum cortisol levels were measured at admission and discharge; in group 2 once. Use of topical corticosteroids 3 months prior to the cortisol measurement was recorded and disease activity was monitored using the Six Area Six Sign Atopic Dermatitis (SASSAD) score and serum thymus and activation-regulated chemokine (TARC) levels.
Results: On admission, basal cortisol levels in group 1 were significantly (p , 0.001) decreased in 80% of the patients. In group 2 the basal cortisol level was normal in all but 3 patients. Group 1 had on admission had a significantly lower cortisol level than group 2 (p , 0.001). Disease activity in group 1 on admission was significantly higher than in group 2 (p , 0.001). There was no difference in use of topical corticosteroids in the 3 months before cortisol measurement. In group 1, at discharge from hospital, basal cortisol levels increased significantly (p , 0.0001) and disease activity (TARC and SASSAD) decreased significantly (p , 0.001). Ongoing investigation reveals that this finding is consistent in a larger group of patients.
Conclusions: Disease activity, rather than the use of topical corticosteroids are responsible for the low basal cortisol values in patients with severe AD. 
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